✦ LIBER ✦

Secretases as targets for beta-amyloid lowering drugs

✍ Scribed by Jochen Walter; Christian Haass

Publisher: John Wiley and Sons
Year: 2002
Tongue: English
Weight: 193 KB
Volume: 56
Category: Article
ISSN: 0272-4391
DOI: 10.1002/ddr.10076

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Chromatin Modifications as Targets for N

Chromatin Modifications as Targets for New Anticancer Drugs

✍ Stefan Schaefer; Manfred Jung 📂 Article 📅 2005 🏛 John Wiley and Sons ⚖ 8 KB 👁 1 views

Chromatin Modifications as Targets for N

Chromatin Modifications as Targets for New Anticancer Drugs

✍ Stefan Schäfer; Manfred Jung 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 150 KB 👁 1 views

β-secretase as a target for the treatmen

β-secretase as a target for the treatment of Alzheimer's disease

✍ Martin Citron 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 490 KB 👁 1 views

## Abstract Finding inhibitors of the first step of the amyloid cascade, Aβ~42~ generation, is a major goal of Alzheimer's disease drug development. Two target protease activities, β‐and γ‐secretase, were detected more than 10 years ago but progress in this area has been slow because the enzymes we

Hsp90 as a Target for Drug Development

✍ Subhabrata Chaudhury; Timothy R. Welch; Brian S. J. Blagg 📂 Article 📅 2007 🏛 John Wiley and Sons ⚖ 11 KB

Farnesyltransferase as a target for anti

Farnesyltransferase as a target for anticancer drug design

✍ Yimin Qian; Saïd M. Sebti; Andrew D. Hamilton 📂 Article 📅 1997 🏛 Wiley (John Wiley & Sons) 🌐 English ⚖ 233 KB 👁 2 views

The currently understood function for Ras in signal transduction is in mediating the transmission of signals from external growth factors to the cell nucleus. Mutated forms of this GTP-binding protein are found in 30% of human cancers with particularly high prevalence in colon and pancreatic carcino

Hsp90 as a Target for Drug Development

✍ Subhabrata Chaudhury; Timothy R. Welch; Brian S. J. Blagg 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 605 KB